Search

Your search keyword '"Senna G"' showing total 32 results

Search Constraints

Start Over You searched for: Author "Senna G" Remove constraint Author: "Senna G" Topic business Remove constraint Topic: business
32 results on '"Senna G"'

Search Results

1. Persistence of both reversible airway obstruction and higher blood eosinophils may predict lung function decline in severe asthma

2. Chronic rhinosinusitis with nasal polyps impact in severe asthma patients: Evidences from the Severe Asthma Network Italy (SANI) registry

3. Clinical features associated with a doctor-diagnosis of bronchiectasis in the Severe Asthma Network in Italy (SANI) registry

4. COVID-19 Vaccination in Pregnancy, Paediatrics, Immunocompromised Patients, and Persons with History of Allergy or Prior SARS-CoV-2 Infection: Overview of Current Recommendations and Pre- and Post-Marketing Evidence for Vaccine Efficacy and Safety

5. Higher blood eosinophil levels after omalizumab treatment may be associated with poorer asthma outcomes

6. Frequency of tiotropium bromide use and clinical features of patients with severe asthma in a real-life setting: Data from the severe asthma network in Italy (sani) registry

7. Characteristics and treatment regimens across ERS SHARP severe asthma registries

8. Relevance of TH2 Markers in the Assessment and Therapeutic Management of Severe Allergic Asthma: A Real-Life Perspective

9. Asthma control in severe asthmatics under treatment with omalizumab: A cross-sectional observational study in Italy

10. The role of mobile apps in allergic respiratory diseases: An italian multicentre survey report

11. Allergic rhinitis: the eligible candidate to mite immunotherapy in the real world

12. SANI-Severe Asthma Network in Italy: A way forward to monitor severe asthma

13. The possible influence of the environment on respiratory allergy: a survey on immigrants to Italy

14. Adherence issues related to sublingual immunotherapy as perceived by allergists

15. Severe asthma: One disease and multiple definitions

16. Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life

17. Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial

18. The potential role of local pharmacies to assess asthma control: an Italian cross-sectional study

19. COVID-19 in Severe Asthma Network in Italy (SANI) patients: Clinical features, impact of comorbidities and treatments

20. Nrf2-interacting nutrients and COVID-19: time for research to develop adaptation strategies

21. Urticaria: recommendations from the Italian Society of Allergology, Asthma and Clinical Immunology and the Italian Society of Allergological, Occupational and Environmental Dermatology

22. Reply to: Kow CS et al. Are severe asthma patients at higher risk of developing severe outcomes from COVID-19?

23. Mepolizumab for severe eosinophilic asthma: a real-world snapshot on clinical markers and timing of response

24. Minimal clinically important difference for asthma endpoints: an expert consensus report

25. Omalizumab in elderly patients with chronic spontaneous urticaria: An Italian real-life experience

26. The Severe Asthma Network in Italy: Findings and Perspectives

27. Choosing wisely: Practical considerations on treatment efficacy and safety of asthma in the elderly

28. Illness perception, mood and coping strategies in allergic rhinitis: are there differences among ARIA classes of severity?

29. A survey of clinical features of allergic rhinitis in adults

30. Anaphylaxis caused by skin prick testing with aeroallergens: Case report and evaluation of the risk in Italian allergy services

31. RhinAsthma patient perspective: a short daily asthma and rhinitis QoL assessment

32. The additional values of microarray allergen assay in the management of polysensitised patients with respiratory allergy

Catalog

Books, media, physical & digital resources